Faul, Elizabeth J <br/><br/>
Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity.  [electronic resource] 

 -  Virology  Dec 2008 
 - 226-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1096-0341 
<br/><br/><label>Standard No.: </label>10.1016/j.virol.2008.09.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--genetics<br/>Adjuvants, Immunologic--genetics<br/>Animals<br/>Antibodies, Viral--biosynthesis<br/>Antigen-Presenting Cells--immunology<br/>Base Sequence<br/>CD8-Positive T-Lymphocytes--immunology<br/>DNA Primers--genetics<br/>Genes, gag<br/>Genetic Vectors<br/>HIV-1--genetics<br/>Immunity, Innate<br/>Immunity, Mucosal<br/>Immunoglobulin G--biosynthesis<br/>Interferon Type I--genetics<br/>Lymphocyte Activation<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Knockout<br/>Rabies virus--genetics<br/>Receptor, Interferon alpha-beta--deficiency<br/>Recombinant Proteins<br/>Recombination, Genetic<br/>Signal Transduction<br/>Virus Replication